Supplemental Figure Legends from Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44

Monika Hartmann,Liseth M. Parra,Anne Ruschel,Sandra Böhme,Yong Li,Helen Morrison,Andreas Herrlich,Peter Herrlich

DOI: https://doi.org/10.1158/1541-7786.22514065.v1

2023-01-01

Abstract:Supplemental Figure Legends S1-S7. Supplemental Figure Legends

What problem does this paper attempt to address?

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Wenqun Zhong,Zhang Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23952936.v1

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xiaohui Fan,Randall J. Brezski,Hui Deng,Pooja Dhupkar,Yun Q. Shi,Anneliese Gonzalez,Songlin Zhang,Michael A. Rycyzyn,William R. Strohl,Robert E. Jordan,Ningyan Zhang,Zhiqiang An

DOI: https://doi.org/10.1158/1535-7163.22501711

2023-01-01

Abstract:Figure S1: IdeS expression in BT474 breast cancer cells Figure S2: Detection of MMPs in cancer cell lysates and culture supernatant Figure S3: scIgG-T was not in the SKBR-3 cell culture medium Figure S4: Detection of immune cells infiltration in mice by flow cytometry.
Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Xiao Lin,Dae Joong Kim,Clayton L. Davis,James V. McCann,James M. Dunleavey,Alissa K. Vanderlinden,Nuo Xu,Samantha G. Pattenden,Stephen V. Frye,Xin Xu,Mark Onaitis,Elizabeth Monaghan-Benson,Keith Burridge,Andrew C. Dudley

DOI: https://doi.org/10.1158/0008-5472.22406702

2023-01-01

Abstract:Legends for Supplemental Figures S1-S7.
Supplementary Figure legend from ETV1-Positive Cells Give Rise to BRAFV600E-Mutant Gastrointestinal Stromal Tumors

Leili Ran,Devan Murphy,Jessica Sher,Zhen Cao,Shangqian Wang,Edward Walczak,Youxin Guan,Yuanyuan Xie,Shipra Shukla,Yu Zhan,Cristina R. Antonescu,Yu Chen,Ping Chi

DOI: https://doi.org/10.1158/0008-5472.22414656.v1

2023-01-01

Abstract:Supplementary Figure legend
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Supplementary Figure Legends from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Marcus Ruscetti,Bill Quach,Eman L. Dadashian,David J. Mulholland,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22405865.v1

2023-01-01

Abstract:Supplementary Figure Legends. Legend for Supplementary Figures S1-S5.
Supplementary Figure Legend from VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth

Natasha Y. Frank,Tobias Schatton,Soo Kim,Qian Zhan,Brian J. Wilson,Jie Ma,Karim R. Saab,Veronika Osherov,Hans R. Widlund,Martin Gasser,Ana-Maria Waaga-Gasser,Thomas S. Kupper,George F. Murphy,Markus H. Frank

DOI: https://doi.org/10.1158/0008-5472.22389243

2023-01-01

Abstract:Supplementary Figure Legend from VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth
Supplemental Figures and Tables Legends from Notch1 Mutations Are Drivers of Oral Tumorigenesis

Evgeny Izumchenko,Kening Sun,Siân Jones,Mariana Brait,Nishant Agrawal,Wayne M. Koch,Christine L. McCord,David R. Riley,Samuel V. Angiuoli,Victor E. Velculescu,Wei‐Wen Jiang,David Sidransky

DOI: https://doi.org/10.1158/1940-6207.22526591

2023-01-01

Abstract:Supplemental Figures and Tables legends
Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407863

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6.
Supplementary Figure Legend from VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells

Xiangcang Ye,Fan,Rajat Bhattacharya,Seth Bellister,Delphine R. Boulbes,Rui Wang,Ling Xia,Cristina Ivan,Xiaofeng Zheng,George A. Calin,Jing Wang,Xiongbin Lu,Lee M. Ellis

DOI: https://doi.org/10.1158/1541-7786.22511929

2023-01-01

Abstract:Supplementary Figure Legend. Supplementary Figure Legend
Supplemental Figure Legends from Notch Pathway Inhibition Using PF-03084014, a Γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer

Di Cui,Jinlu Dai,Jill M. Keller,Atsushi Mizokami,Shujie Xia,Evan T. Keller

DOI: https://doi.org/10.1158/1078-0432.22460979.v1

2023-01-01

Abstract:Supplemental Figure Legends
Supplementary Figure Legends 1-7 from Nestin is Required for Spindle Assembly and Cell-Cycle Progression in Glioblastoma Cells

Qinglin Wang,Hao Wu,Jinglu Hu,Haijuan Fu,Yanghui Qu,Yang Yao,Kathy Q. Cai,А. В. Ефимов,Mei X. Wu,Tim J. Yen,Yuan Wang,Zeng-jie Yang

DOI: https://doi.org/10.1158/1541-7786.22527155.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-7
Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis

Pengxu Qian,Zehua Zuo,Zhengsheng Wu,Xianyi Meng,Gaopeng Li,Zhengzhou Wu,Weijie Zhang,Sheng Tan,Vijay Pandey,Yandan Yao,Puyue Wang,Liqing Zhao,Jun Wang,Qiang Wu,Erwei Song,Peter E. Lobie,Zhinan Yin,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22391054

2023-01-01

Abstract:PDF file - 214K
Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Xiaohong Wu,Govind Ragupathi,Katherine S. Panageas,Feng Hong,Philip O. Livingston

DOI: https://doi.org/10.1158/1078-0432.22446662

2023-01-01

Abstract:Legend for supplementary figures - PDF file 62K, Supplementary Figure Legend
Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Huafeng Wei,Hao Wang,Bing Lu,Bohua Li,Sheng Hou,Weizhu Qian,Kexing Fan,Jianxin Dai,Jian Zhao,Yajun Guo

DOI: https://doi.org/10.1158/0008-5472.22375065.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Supplementary Figure Legends from Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors

Yong Li,Shunqun Luo,Ruihua Ma,Jing Liu,Pingwei Xu,Huafeng Zhang,Ke Tang,Jingwei Ma,Yi Zhang,Xiaoyu Liang,Yanling Sun,Tiantian Ji,Ning Wang,Bo Huang

DOI: https://doi.org/10.1158/0008-5472.22410020

2023-01-01

Abstract:Legends for Supplementary Figures S1-S8.
Supplemental Figure Legends from STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

Heng Yang,Takahiro Yamazaki,Federico Pietrocola,Heng Zhou,Laurence Zitvogel,Yuting Ma,Guido Kroemer

DOI: https://doi.org/10.1158/0008-5472.22404671

2023-01-01

Abstract:Supplemental Figure Legends. Supplemental Figure Legends
Supplementary Figure Legend from Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody

George A. Dominguez,Thomas Condamine,Sridevi Mony,Ayumi Hashimoto,Fang Wang,Qin Liu,Andres Forero,Johanna C. Bendell,Robert L. Witt,Neil Hockstein,Prasanna Kumar,Dmitry I. Gabrilovich

DOI: https://doi.org/10.1158/1078-0432.22461995.v1

2023-01-01

Abstract:Supplementary Figure Legend
Supplementary Figure Legends 1-4 from the Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating Cdc42 Recruitment and Activity

Shumin Zhang,Katherine Schafer-Hales,Fadlo R. Khuri,Wei Zhou,Paula M. Vertino,Adam I. Marcus

DOI: https://doi.org/10.1158/0008-5472.22374815

2023-01-01

Abstract:Supplementary Figure Legends 1-4 from The Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating cdc42 Recruitment and Activity

Supplemental Figure Legends from Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Supplementary Figure legend from ETV1-Positive Cells Give Rise to <i>BRAF<sup>V600E</sup></i>-Mutant Gastrointestinal Stromal Tumors

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Figure Legend from VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth

Supplemental Figures and Tables Legends from Notch1 Mutations Are Drivers of Oral Tumorigenesis

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legend from VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells

Supplemental Figure Legends from Notch Pathway Inhibition Using PF-03084014, a Γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer

Supplementary Figure Legends 1-7 from Nestin is Required for Spindle Assembly and Cell-Cycle Progression in Glioblastoma Cells

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplementary Figure Legends from Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors

Supplemental Figure Legends from STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

Supplementary Figure Legend from Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody

Supplementary Figure Legends 1-4 from the Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating Cdc42 Recruitment and Activity

Supplemental Figure Legends from Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Supplementary Figure legend from ETV1-Positive Cells Give Rise to &lt;i&gt;BRAF&lt;sup&gt;V600E&lt;/sup&gt;&lt;/i&gt;-Mutant Gastrointestinal Stromal Tumors

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Figure Legend from VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth

Supplemental Figures and Tables Legends from Notch1 Mutations Are Drivers of Oral Tumorigenesis

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legend from VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells

Supplemental Figure Legends from Notch Pathway Inhibition Using PF-03084014, a Γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer

Supplementary Figure Legends 1-7 from Nestin is Required for Spindle Assembly and Cell-Cycle Progression in Glioblastoma Cells

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced &lt;i&gt;let-7g&lt;/i&gt; Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplementary Figure Legends from Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors

Supplemental Figure Legends from STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

Supplementary Figure Legend from Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody

Supplementary Figure Legends 1-4 from the Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating Cdc42 Recruitment and Activity

Supplementary Figure legend from ETV1-Positive Cells Give Rise to <i>BRAF<sup>V600E</sup></i>-Mutant Gastrointestinal Stromal Tumors

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis